Form 8-K - Current report:
SEC Accession No. 0001193125-13-036956
Filing Date
2013-02-04
Accepted
2013-02-04 17:28:59
Documents
3
Period of Report
2013-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d478169d8k.htm 8-K 26144
2 TRANSITION AND SEPARATION LETTER AGREEMENT d478169dex101.htm EX-10.1 199694
3 EMPLOYMENT AGREEMENT d478169dex102.htm EX-10.2 61888
  Complete submission text file 0001193125-13-036956.txt   289037
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 13571181
SIC: 2835 In Vitro & In Vivo Diagnostic Substances